beclamide beclamide beclamide (marketed as chloracon, hibicon, posedrine, nydrane, seclar, and other names) is a drug that possesses anticonvulsant activity. it is no longer used. beclamideclinical dataroutes ofadministrationby mouthatc coden03ax30 (who) identifiers iupac name n-benzyl-3-chloropropanamide cas number501-68-8 ypubchem cid10391chemspider9962 yuniif5n0ali65vkeggd07300 ychemblchembl64195 ycomptox dashboard (epa)dtxsid5057755 echa infocard100.007.207 chemical and physical dataformulac10h12clnomolar mass197.66 g·mol−13d model (jsmol)interactive imagemelting point94 °c (201 °f) smiles clccc(=o)ncc1ccccc1 inchi inchi=1s/c10h12clno/c11-7-6-10(13)12-8-9-4-2-1-3-5-9/h1-5h,6-8h2,(h,12,13) ykey:jpyqfyieouvjdu-uhfffaoysa-n y (verify) uses it has been used as a sedative and as an anticonvulsant. it was studied in the 1950s for its anticonvulsant properties, as a treatment for generalised tonic-clonic seizures. it was not effective for absence seizures. interest in the drug resumed in the 1990s for its psychiatric properties as an adjunct in the treatment of schizophrenia. side effects side effects are uncommon but include stomach pain, nervousness, giddiness, skin rash and leukopenia. it is counter-indicated in breast feeding as it is passed in the milk. administration and pharmacology administration is oral, though it has an unpleasant taste. it is quickly absorbed and elimination is renal and complete within 48 hours. beclamide is possibly metabolized to 3-chloropropanoic acid in vivo, which binds to the ghb receptor.